Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04522089
Recruitment Status : Active, not recruiting
First Posted : August 21, 2020
Last Update Posted : October 18, 2021
Sponsor:
Information provided by (Responsible Party):
Adimmune Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : November 20, 2020
Estimated Study Completion Date : October 31, 2021